Research Article| Volume 4, ISSUE 4, P703-716, December 1984

Diagnosis of Pheochromocytoma

  • John H. Eckfeldt
    Corresponding author: Section of Clinical Chemistry and Toxicology, Laboratory Service (113), Veterans Administration Medical Center, Minneapolis, Minnesota 55417
    Chief, Clinical Chemistry and Toxicology, Veterans Administration Medical Center; Associate Professor of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis, Minnesota
    Search for articles by this author
  • Karl Engelman
    Chief, Hypertension and Clinical Pharmacology Section, Hospital of the University of Pennsylvania; Associate Professor of Medicine and Pharmacology, University of Pennsylvania Medical School, Philadelphia, Pennsylvania
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.
      This article reviews the pathophysiology and clinical features of pheochromocytoma, along with the biochemical approaches that have been used for confirming its diagnosis. Different methods for urinary, plasma, and platelet catecholamines and catecholamine catabolites are discussed, and the authors’ opinions on which test(s) to use and which patients to screen are presented.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.


      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Atuk N.O.
        Pheochromocytoma: Diagnosis, localization, and treatment.
        Hosp. Pract. 1983; 18: 187-202
        • Bauersfeld W.
        • Diener U.
        • Knoll E.
        • et al.
        Determination of urinary vanillylmandelic acid and homovanillic acid by high performance liquid chromatography with amperometric detection.
        J. Clin. Chem. Clin. Biochem. 1982; 20: 217-220
        • Borrello G.
        Urinary catecholamines in pheochromocytoma.
        Am. Heart J. 1983; 105 (letter): 697
        • Bravo E.L.
        • Tarazi R.C.
        • Gifford R.W.
        • et al.
        Circulating and urinary catecholamines in pheochromocytoma.
        N. Engl. J. Med. 1979; 301: 682-686
        • Bravo E.L.
        • Tarazi R.C.
        • Fouad F.M.
        • et al.
        Clonidine-suppression test: A useful aid in the diagnosis of pheochromocytoma.
        N. Engl. J. Med. 1981; 305: 623-626
        • Brown M.J.
        Catecholamine measurements in clinical medicine.
        Postgrad. Med. J. 1983; 59: 479-482
        • Brown M.J.
        • Lewis P.J.
        Clonidine-suppression test for diagnosis of pheochromo cytoma.
        N. Engl. J. Med. 1982; 306 (letter): 49
        • Brown M.J.
        • Allison D.J.
        • Jenner D.A.
        • et al.
        Increased sensitivity and accuracy of phaeochromocytoma diagnosis achieved by use of plasma adrenaline-estimations and a pentolinium-suppression test.
        Lancet. 1981; 1: 174-177
        • Burris J.F.
        • D’Angelio L.J.
        Complications of clonidine suppression test for pheochromocytoma.
        N. Engl. J. Med. 1982; 307 (letter): 756-757
        • Causon R.C.
        • Brown M.J.
        Catecholamine measurements in phaeochromocytoma: A review.
        Ann. Clin. Biochem. 1982; 19: 396-404
        • Chauhan M.S.
        • Dakshinamurti K.
        Gas chromatographic method for the simultaneous determination of dopamine and norepinephrine metabolites.
        J. Chromatogr. 1982; 227: 323-330
        • Chou D.
        • Tsuru M.
        • Holtzman J.
        • et al.
        Interference by the 4-hydroxylated metabolites of propranolol with the determination of metanephrines by the Pisano method.
        Clin. Chem. 1980; 26: 776-777
        • Coyle J.T.
        • Henry D.
        Catecholamine in fetal and newborn rat brain.
        J. Neurochem. 1973; 21: 61-67
        • Crout J.R.
        Catecholamines in urine.
        in: Seligson D. Standard Methods of Clinical Chemistry. Vol. 3. Academic Press, New York1960: 62-80
        • Crout J.R.
        • Pisano J.J.
        • Sjoerdsma A.
        • et al.
        Urinary excretion of catecholamines and their metabolites in pheochromocytoma.
        Am. Heart J. 1961; 61: 376-381
        • Da Prada M.
        • Zürcher G.
        Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range.
        Life Sei. 1976; 19: 1161-1174
        • Engelman K.
        Clin. Endocrinol. Metab. 1977; 6: 769-797
        • Engelman K.
        • Portnoy B.
        • Sjoerdsma A.
        Plasma catecholamine concentrations in patients with pheochromocytoma.
        Circ. Res. 1970; 26 and 27: 1141-1146
        • Estigarribia J.A.
        • Lucas C.P.
        Elevated catecholamine levels in hypertension. Basis for misdiagnosis of pheochromocytoma in three patients.
        Postgrad. Med. 1983; 73: 289-292
        • Feldman J.M.
        Platelet catecholamine content in pheochromocytoma.
        N. Engl. J. Med. 1982; 307 (letter): 756
        • Feldman J.M.
        • Klatt C.
        Elevated platelet norepinephrine concentration in patients with pheochromocytomas.
        Clin. Chim. Acta. 1981; 117: 279-288
        • Fujita K.
        • Maruta K.
        • Ito S.
        • et al.
        Urinary 4-hydroxy-3-methoxymandelic (vanillyl-mandelic) acid, 4-hydroxy-3-methoxyphenylacetic (homovanillic) acid, and 5-hydroxy-3-indoleacetic acid determined by liquid chromatography with electrochemical detection.
        Clin. Chem. 1983; 29: 876-878
        • Galen R.S.
        • Gambino R.
        Beyond Normality: The Predictive Value and Efficiency of Laboratory Diagnosis.
        John Wiley and Sons, New York1975: 62-70
        • Ganguly A.
        • Henry D.
        • Yune H.
        • et al.
        Diagnosis and localization of pheochromocytoma: Detection by measurement of urinary norepinephrine excretion during sleep, plasma norepinephrine concentration and computerized axial tomography (CT-Scan).
        Am. J. Med. 1979; 67: 21-26
        • Gitlow S.
        • Mendlowitz M.
        • Bertani L.
        The biochemical techniques for detecting and establishing the presence of a pheochromocytoma.
        Am. J. Cardiol. 1970; 26: 270-279
        • Hallman H.
        • Farnebo L.
        • Hamberger B.
        • et al.
        A sensitive method for determination of plasma catecholamines using liquid chromatography with electrochemical detection.
        Life Sei. 1978; 23: 1049-1052
        • Halter J.
        • Beard J.
        • Pfeifer M.
        Clonidine-suppression test for diagnosis of pheochromocytoma.
        N. Engl. J. Med. 1982; 306 (letter): 49-50
        • Hamberger B.
        • Arner S.
        • Eskilsson P.
        • et al.
        Plasma catecholamine levels in the diagnosis and management of pheochromocytoma.
        Surg. Gynecol. Obstet. 1981; 152: 291-296
        • Hamilton B.
        • Landsberg L.
        • Levine L.
        Measurement of urinary epinephrine in screening for pheochromocytoma in multiple endocrine neoplasia type II.
        Am. J. Med. 1978; 65: 1027-1032
        • Hattner R.
        • Englestad B.
        • Roizen M.
        • et al.
        Platelet catecholamine content in pheochromocytoma.
        N. Engl. J. Med. 1982; 307 (letter): 755-756
        • Jackman G.
        A simple method for the assay of urinary metanephrines using high performance liquid chromatography with fluorescence detection.
        Clin. Chim. Acta. 1982; 120: 137-142
        • Jenner D.
        • Brown M.
        • Lhoste F.
        Determination of alpha-methyldopa, alpha-methylnoradrenaline, noradrenaline, and adrenaline in plasma using HPLC with electrochemical detection.
        J. Chromatogr. 1981; 224: 507-512
        • Jones D.
        • Reid J.
        • Hamilton C.
        • et al.
        The biochemical diagnosis, localization and follow up of pheochromocytoma: The role of plasma and urinary catecholamine measurements.
        Q. J. Med. 1980; 49: 341-361
        • Jouve J.
        • Mariotte N.
        • Sureau C.
        • et al.
        High performance liquid chromatography with electrochemical detection for the simultaneous determination of the methoxylated amines, normetanephrine, metanephrine and 3-methoxytyramine in urine.
        J. Chromatogr. 1983; 274: 53-62
        • Kalif V.
        • Shapiro B.
        • Lloyd R.
        • et al.
        The spectrum of pheochromocytoma in hypertensive patients with neurofibromatosis.
        Arch. Intern. Med. 1982; 142: 2092-2098
        • Kaplan N.
        • Kramer N.
        • Holland O.
        Single-voided urine metanephrine assays in screening for pheochromocytoma.
        Arch. Intern. Med. 1977; 137: 190-193
        • Krustulovic A.
        Investigations of catecholamine metabolism using high-performance liquid chromatography: Analytical methodology and clinical applications.
        J. Chromatogr. 1982; 229: 1-34
        • L’Abbé M.
        • Tinel J.
        • Doumer A.
        Crisis solaries et hypertension paroxystique enrapport avec une tumeur surrenale.
        Bulletin et Memoires de la Societe Medical des Hospitaux de Paris. 1922; 46: 982-990
        • Lagana A.
        • Rotatori M.
        High-performance liquid chromatographic procedure for the analysis of urinary 3-methoxy-4-hydroxymandelic acid.
        J. Chromatogr. 1983; 275: 168-173
        • Leiendpcker-Foster C.
        • Freier E.
        Improved simultaneous gas-chromatographic analysis for homovanillic acid and vanillylmandelic acid in urine.
        Clin. Chem. 1981; 27: 2029-2032
        • Mayo C.
        Paroxysmal hypertension with tumor of retroperitoneal nerve.
        J.A.M.A. 1927; 139: 1047-1050
        • Modlin I.M.
        • Farndon J.R.
        • Shepherd A.
        Phaeochromocytomas in 72 patients: Clinical and diagnostic features, treatment and long term results.
        Br. J. Surg. 1979; 66: 456-465
        • Moleman P.
        • Borstrok J.J.
        Determination of urinary vanillylmandelic acid by liquid chromatography with electrochemical detection.
        Clin. Chem. 1983; 29: 878-881
        • Muskiet F.A.
        • Fremouw-Ottevangers D.C.
        • Wolthers B.G.
        Gas chromatographic profiling of urinary acid and alcoholic catecholamine metabolites.
        Clin. Chem. 1977; 23: 863-867
        • Nanji A.A.
        • Blank D.
        Increased 24 hour urine vanillylmandelic acid in patients with pheochromocytoma.
        Am. Heart J. 1982; 103 (letter): 1088
        • Nanji A.A.
        • Campbell D.J.
        Pheochromocytoma: Which tests are best?.
        Diagn. Med. 1982; 5: 52-56
        • Oishi S.
        Random one-hour urine catecholamine and 4-hydroxy-3-methoxymandelic acid assays for diagnosis of pheochromocytoma.
        Clin. Chim. Acta. 1980; 103: 335-342
        • Ong H.
        • Capet-Antonini F.
        • Yamaguchi N.
        • et al.
        Simultaneous determination of free 3-methoxy-4-hydroxymandelic acid and free 3-methoxy-4-hydroxyphenylethyleneglycol by liquid chromatography with electrochemical detection.
        J. Chromatogr. 1982; 233: 97-105
        • Orsulak P.J.
        • Kizuka P.
        • Grab E.
        • et al.
        Determination of urinary normetanephrine and metanephrine by radial-compression liquid chromatography and electrochemical detection.
        Clin. Chem. 1983; 29: 305-309
        • Pick L.
        Das ganglioma embryuonale sympathicum (sympathoma embryonale), eine typische bösartige geschwuestform, des sympathischen nervensystems.
        Klin. Wochenschr. 1912; 19: 16-26
        • Pisano J.
        A simple analysis for normetanephrine and metanephrine in urine.
        Clin. Chim. Acta. 1960; 5: 406-414
        • Pisano J.
        • Crout R.
        • Abraham D.
        Determination of 3-methoxy-4-hydroxymandelic acid in urine.
        Clin. Chim. Acta. 1962; 7: 285-291
        • Pisano J.
        Assay of catecholamine metabolites based on vanillin formation.
        in: Berson S. Rail J. Koplin I. Methods in Investigative and Diagnostic Endocrinology. Elsevier, New York1972: 474-488
        • Raum W.
        • Swerdloff R.
        Urinary metanephrine radioimmunoassay: Comparison with the colorimetric assay.
        Clin. Chem. 1981; 27: 43-47
        • Rayfield E.J.
        • Cain J.P.
        • Casey M.P.
        • et al.
        Influence of diet on urinary VMA excretion.
        J. Am. Med. Assoc. 1972; 221: 704-705
        • Schleicher E.D.
        • Kees F.K.
        • Wieland O.H.
        Analysis of total urinary catecholamines by liquid chromatography: Methodology, routine experience and clinical interpretations of results.
        Clin. Chim. Acta. 1983; 129: 295-302
        • Sjoerdsma A.
        • Engelman K.
        • Waldmann T.
        • et al.
        Pheochromocytoma: Current concepts of diagnosis and treatment.
        Ann. Intern. Med. 1966; 65: 1302-1326
        • Soldin S.J.
        • Lam G.
        • Pollard A.
        • et al.
        High performance liquid chromatographic analysis of urinary catecholamines employing amperometric detection: Reference values and use in laboratory diagnosis of neural crest tumors.
        Clin. Biochem. 1980; 13: 285-291
        • Stenstrom G.
        • Sjogren B.
        • Waldenstrom J.
        Excretion of adrenaline, noradrenaline, vanillylmandelic acid and metanephrines in 64 patients with pheochromocytoma. Results of repeated analyses in patients with sustained and paroxysmal hypertension.
        Acta Med. Scand. 1983; 214: 145-152
        • Sullivan J.
        • Solomon H.
        The diagnosis of pheochromocytoma: Overnight excretion of catecholamine metabolites.
        J.A.M.A. 1975; 231: 618-619
        • Tuchman M.
        • Crippin P.J.
        • Krivit W.
        Capillary gas-chromatography determination of urinary homovanillic acid and vanillylmandelic acid.
        Clin. Chem. 1983; 29: 828-831
        • van de Calseyde J.F.
        • Scholtis R.H.
        • Schmidt N.A.
        • et al.
        Gas chromatography in the estimation of urinary metanephrines and VMA.
        Clin. Chim. Acta. 1971; 32: 361-366
        • van Heerden J.A.
        • Sheps S.G.
        • Hamberger B.
        • et al.
        Pheochromocytoma: Current status and changing trends.
        Surgery. 1982; 91: 367-373
        • Webb T.A.
        • Sheps S.G.
        • Carney J.A.
        Differences between sporadic pheochromocytoma and pheochromocytoma in multiple endocrine neoplasia, type 2.
        Am. J. Surg. Pathol. 1980; 4: 121-126
        • Weinstein M.C.
        • Fineberg H.V.
        Cost effective analysis for medical practices: Appropriate laboratory utilization.
        in: Rubin M. Benson E. The Logic and Economics of Laboratory Use. Elsevier, New York1978: 3-32
        • Yoshida A.
        • Yoshioka M.
        • Sakia T.
        • et al.
        Simple method for the determination of homovanillic acid and vanillylmandelic acid in urine by high-performance liquid chromatography.
        J. Chromatogr. 1982; 227: 162-167
        • Young D.S.
        • Pestaner L.C.
        • Gibberman V.
        Effects of drugs on clinical laboratory tests.
        Clin. Chem. 1975; 21 (special issue): 328D-388D
        • Zweifler A.J.
        • Julius S.
        Increased platelet catecholamine content in pheochromocytoma: A diagnostic test in patients with elevated plasma catecholamines.
        N. Engl. J. Med. 1982; 306: 890-894
        • Zweifler A.J.
        • Julius S.
        Platelet catecholamine content in pheochromocytoma.
        N. Engl. J. Med. 1982; 307 (letter): 756